Public Health
Intelligence
Public pharmaceutical procurement intelligence for governments, ministries, and public health institutions.
Market Opportunity
Unified pharmaceutical procurement oversight for national health systems — real-time transparency and institutional intelligence
Government health ministries and public health institutions face an operational paradox: they generate procurement data (SICOP logs every tender from CAJA, INS, Ministry of Health, regional hospitals), but lack real-time visibility into system-wide buying patterns, supplier performance, and institutional spend trends. This opacity costs lives and budgets. SICOP Health Intelligence centralizes all pharmaceutical and medical procurement across your nation's public health system into a single, real-time dashboard.
The Institutional Challenge
Why Now
Core Capabilities
Complete procurement oversight for public health institutions
System-Wide Procurement Dashboard
- Real-time view of all active tenders across CAJA, INS, Ministry of Health, and regional hospitals
- Status tracking: open for bids, closing in 48h, awarded, adjudicated, at-risk
- Institutional breakdown: agency, budget spent, supplier awarded, procurement timeline
- Customizable alerts for high-risk procurement (price spikes >15%, blacklisted supplier reappears)
Institutional Intelligence
- Demand forecasting: track multi-year buying patterns by institution
- Supplier risk monitoring: bid concentration, repeated quality issues
- Cross-institutional duplication detection: save 20%+ through consolidated procurement
- Budget optimization: identify highest-spend areas; negotiate regional contracts
Strategic Watchlist + Supply Chain
- Automatic tracking of 172 bioequivalent pharmaceutical variants
- Automatic tracking of 404 difficult-to-source supply items
- Alert when watchlist items enter shortage before stock hits zero
- Supply chain bottleneck detection across institutional procurement cycles
Price & Contract Tracking
- Historical price data for 2,020+ awarded contracts (Costa Rica, 2020–present)
- Price trend analysis: detect supplier exploitation vs. justified price changes
- Competitor intelligence: private vs. public supplier bid comparison
- Seasonality patterns: forecast institutional budget needs
Business Outcomes
Measurable results for public health institutions
Reduction in procurement cycle time
Reduction in pharmaceutical procurement spend
Fewer emergency procurement events
Critical supply stockouts
Operational Efficiency
Before
Procurement officers manually monitor SICOP. Tender review lag: 2–3 weeks post-publication. Risk signals go unnoticed until budget impact is visible.
With SICOP HI
Real-time dashboard surfaces all tenders within 1 hour. Alerts flag risk immediately. Approve or reject tenders in 48 hours, not 3 weeks.
Cost Containment
Before
Paying 20% premium when supplier offered lower rate to a peer institution. 12 separate tenders for the same insumo.
With SICOP HI
Price trend data informs negotiation. Consolidated procurement with volume discounts. Watchlist alerts prevent emergency procurement at 30% markup.

